Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Add Event To Calendar

Save the event dates in your Outlook calendar

Find another IIR Event

Event Search Form by Industry

Drug-Induced Hepatotoxicity

The Only Industry, Academia & Government Event on Improving Techniques for Predicting Drug Induced Liver Injury Throughout the Entire Development Process

May 17 - 18, 2007 | Doubletree Hotel Washington DC


Agenda Day One

Agenda Day One

Thursday, May 17, 2007

This is just a snapshot of Day One. For full details, please download our brochure.

8:00 | Registration & Morning Coffee
8:30 | Conference Chair's Opening Remarks

Rich Miller, DVM, PhD, DACVP
VP, Safety Assessment
GLAXOSMITHKLINE

8:45 | Advancements & Updates in Prediction Techniques

James W. Freston, MD, PhD
Professor of Medicine Emeritus & Boehringer Ingelheim Chair of Clinical Pathology
UNIVERSITY OF CONNECTICUT HEALTH CENTER

9:30 | PANEL DISCUSSION
The Future - Integration and the Prediction Direction

Michael D. DuVall, DVM, PhD
Group Leader Toxicology & Safety Pharm., Global Preclinical Safety
ABBOTT LABORATORIES

William B Mattes, PhD
Director of Toxicology
THE CRITICAL PATH INSTITUTE

Jeff Lawrence
Director of Biochemical Toxicology & Biomarkers
AMGEN 

Donna Mendrick, PhD
Scientific Fellow & VP Toxicogenomics
GENE LOGIC

Christine Hunt, MD
Director of Global Hepatic Safety, Clinical Safety
GLAXOSMITHKLINE

James W. Freston, MD, PhD
Professor of Medicine Emeritus & Boehringer Ingelheim Chair of Clinical Pathology
UNIVERSITY OF CONNECTICUT HEALTH CENTER

10:15 | 30-Minute Break
10:45 | Monitor Liver Function in Pre-Clinical to Identify Potential Liver Toxicity in Humans

Michael D. DuVall, DVM, PhD
Group Leader Toxicology & Safety Pharm., Global Preclinical Safety
ABBOTT LABORATORIES

11:30 | Strategies to Reduce NCE Attrition Due to Liver Toxicity-Designing Novel Screening Methods

Yvonne Will, PhD
Group Leader: Molecular, Cellular & Biochemical Toxicology
PFIZER 

12:15 | Luncheon
1:30 | Use of Pharmacogenomics to Discover Translational Biomarkers

Donna Mendrick, PhD
Scientific Fellow and VP Toxicogenomics
GENE LOGIC, INC.

2:15 | Is it the Liver or Something Else? Overcome Challenges Associated with Testing for Hepatotoxicity

Debra Laskin, PhD
Professor & Chair, Dept. of Pharmacology & Toxicology
RUTGERS UNIVERSITY 

3:00 | Determinants of Susceptibility to Drug-Induced Liver Injury — Inflammatory Stress and Animal Models

Robert Roth, PhD
Assoc. Director for Toxicology Research, National Center for Food Safety & Toxicology
MICHIGAN STATE UNIVERSITY

3:45 | 15-Minute Break
4:00 | The Clinical Presentation & Evaluation of Drug-Induced Liver Injury: Is this Disease or Adaptation?

Christine Hunt, MD
Director of Global Hepatic Safety, Clinical Safety
GLAXOSMITHKLINE 

4:45 | Day One Concludes

Registration

Online Registration is open!

Send To A Friend

Invite a colleague to join you at this event

Media Partners

  • GCPj

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.